Indeed, in human glioblastoma patients, the phosphorylation of 6-phosphogluconate dehydrogenase, another PPP enzyme frequently upregulated in cancer cells, at Tyr481 by Fyn is associated with increased Fyn expression and with reduced survival and worse prognosis [110]. Here, FYN is linked to cancer.